NDC 65757-401 – Aristada
Aripiprazole Lauroxil 441 mg/1.6mL · Injection, Suspension, Extended Release · Intramuscular
Product NDC65757-401
Product details
- Brand name
- Aristada
- Generic name
- Aripiprazole lauroxil
- Labeler
- Alkermes, Inc.
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Intramuscular
- Marketing category
- NDA · NDA207533
- Marketed since
- October 5, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Aripiprazole Lauroxil 441 mg/1.6mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65757-401-03 | 1 SYRINGE in 1 CARTON (65757-401-03) / 1.6 mL in 1 SYRINGE | Oct 5, 2015 |
| 65757-401-04 sample | 1 SYRINGE in 1 CARTON (65757-401-04) / 1.6 mL in 1 SYRINGE | Oct 5, 2015 |
Other Aristada products
- 65757-402 Aripiprazole Lauroxil 662 mg/2.4mL · Injection, Suspension, Extended Release · Alkermes, Inc.
- 65757-403 Aripiprazole Lauroxil 882 mg/3.2mL · Injection, Suspension, Extended Release · Alkermes, Inc.
- 65757-404 Aripiprazole Lauroxil 1064 mg/3.9mL · Injection, Suspension, Extended Release · Alkermes, Inc.